Clinical Trial Update: Psilocybin to Treat Depression in Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating psilocybin for depression in individuals with spinal cord injury is listed as not yet recruiting. The study is sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Spinal Cord Injury

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: James J. Peters Veterans Affairs Medical Center | Conditions: Spinal Cord Injury, Depression - Major Depressive Disorder | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING